Announcements Trials
Browse Landscape

Status

Completed 21Terminated 5Recruiting 3Withdrawn 2Unknown 1Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 9Skin Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Basal Cell 2Xeroderma Pigmentosum 1Uveal Melanoma 1Tuberous Sclerosis 1Tinnitus 1Thyroid Neoplasms 1Tension-Type Headache 1Stroke 1Stress Disorders, Post-Traumatic 1Spinal Stenosis 1Spinal Cord Injuries 1Renal Insufficiency, Chronic 1Pulmonary Disease, Chronic Obstructive 1Psoriasis 1Phantom Limb 1Parkinson Disease 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Osteoporosis 1Osteoarthritis 1Neuroendocrine Tumors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Basal Cell Nevus Syndrome × Dermatologic × Clear all
NCT06330324 2025-05-18

REPRO-ISD

Maastricht University Medical Center

Enrolling by invitation
650 enrolled
Dermatologic

Albinism, Basal Cell Nevus Syndrome, Cutis Laxa, Ectodermal Dysplasia, Epidermolysis Bullosa, Ichthyosis, Keratoderma, Palmoplantar, Tuberous Sclerosis, Xeroderma Pigmentosum, Birt-Hogg-Dube Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡